Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S1 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine
  1. Home
  2. Publications
  3. Figure S1 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine

Figure S1 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine

Authors:
  • ECEvan C. Chen
    Evan C. Chen
  • YLYiwen Liu
    Yiwen Liu
  • HBHayden L. Bell
    Hayden L. Bell
  • JRJeremy Ryan
    Jeremy Ryan
  • JWJason Wu
    Jason Wu
  • EMEmma-Jayne Minihane
    Emma-Jayne Minihane
  • MLMarlise R. Luskin
    Marlise R. Luskin
  • EWEric S. Winer
    Eric S. Winer
  • RVRahul Vedula
    Rahul Vedula
  • VVVirginia Volpe
    Virginia Volpe
  • MSMaximilian Stahl
    Maximilian Stahl
  • DRDaniel Roberts
    Daniel Roberts

Open Access
Publisher website
Google Scholar
  • 14 August 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33253211
Abstract
Figure S1 from Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine
Keywords
  • MYELOID NEOPLASMS
  • ADVANCED MYELOID
  • DUAL BCL-XL
  • DOSE-ESCALATION STUDY
  • DECITABINE FIGURE
  • VENETOCLAX
  • INHIBITION
  • NEOPLASMS
  • NAVITOCLAX
  • DUAL
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.